Plasma Fractionation Market to Reach USD 38.65 Bn by 2026, Kedrion Biopharma’s FDA Approval to Create Attractive Growth Opportunities: Fortune Business Insights

Ads

You May Also Like

Incysus Scientific Co-Founder to Present at Immuno-Oncology Summit

HAMILTON, Bermuda, Aug. 23, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd, a biopharmaceutical company focused ...

Selecta Biosciences to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

BeiGene Announces Proposed Public Offering

CAMBRIDGE, Mass. and BEIJING, China, Jan. 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a ...